Hume Care vs MEDVi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated September 15, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

36 providers verified independently·Independent research·How we rank →

Short answer: MEDVi scores higher on our rubric, 5.7/10 against 3.8/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit MEDVi - our pick of these two →or find your match

MEDVi beats Hume Care overall, scoring 5.7/10 vs 3.8/10. Published pricing is not a like-for-like monthly comparison: Hume Care is from $199/mo; MEDVi is $179 first month, then $299/mo. Choose Hume Care for readers comparing a self-pay glp-1 program with connected app and body-composition tracking. Choose MEDVi for users who want both oral and injectable compounded options in one telehealth program.

A side-by-side look at Hume Care and MEDVi to help you decide. We compare them on:

•Starting price and billing period
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Hume Care

#35 of 36

3.8/10

Hume Care is a prescribing-access program operated by Hume Health Care LLC, distinct from Hume’s device-only products. Its GLP-1Rx page advertises $199 monthly with medication if prescribed and care. The terms identify an independent clinical network and link to MDIntegrations. Specific pharmacy, dose-level prices and consistent clinical-leadership details remain unverified.

Visit Hume Care

Higher Rated

MEDVi

#25 of 36

5.7/10

MEDVi offers a weekly compounded GLP-1 injection and a daily compounded tablet. The injection is $179 for month one and $299 for refills. Trustpilot is 4.3 out of 5 across 14,680 reviews, while BBB is F/not accredited. FDA warning letter #721455 concerns misleading labeling and marketing, not an allegation that the medication was unsafe.

Visit MEDVi

Feature	Hume Care	MEDVi
Our Score	3.8/10	5.7/10
Headline Price	from $199/mo	$179 first month, then $299/mo
Medication Type	Compounded	Both
Insurance Accepted	Self-pay only under the current terms; not a Medicare or insurance coverage route.	No
Best For	Readers comparing a self-pay GLP-1 program with connected app and body-composition tracking	Users who want both oral and injectable compounded options in one telehealth program
Watch out for	No verified dispensing pharmacy in the sources reviewed	FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
Ranking	#35	#25
Get started	Visit Hume Care	Visit MEDVi

Pros & Cons Compared

Hume Care

Pros

+Published $199 monthly GLP-1Rx offer with care and medication if prescribed
+Connected app for logging and program support
+Independent clinical network and legal entity identified in terms

Cons

−No verified dispensing pharmacy in the sources reviewed
−Oral formulation and dose-specific prices are not sufficiently clear to compare
−Clinical-leadership details differ across public pages
−Independent treatment outcomes and customer-review totals have not been established

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+The landing page says the program is HSA and FSA eligible and includes dietician visits and care coaching, with a footnote making that subject to insurance and copay eligibility
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179 covers the first month of compounded semaglutide on MEDVi's landing page, including physician review, the personalized plan, medication and free shipping

Cons

−FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
−Its third-party records conflict: 4.3 out of 5 across 14,680 Trustpilot reviews with 12 percent of them at one star, against an F and no accreditation at the BBB
−The $179 semaglutide price covers month one only; the FAQ on MEDVi's own landing page says refills are locked in at $299 a month, making the first year $3,468 rather than $2,148
−Brand-name Wegovy and Zepbound paths add a $99 membership plus a medication cost the page does not publish, and the same page's hero says "No membership or hidden fees!" directly above those cards; availability is subject to change
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

Our Verdict

MEDVi edges out Hume Care with a score of 5.7/10 vs 3.8/10. Published pricing is not a like-for-like monthly comparison: Hume Care is from $199/mo; MEDVi is $179 first month, then $299/mo. MEDVi offers both brand-name and compounded medications, giving you more flexibility.

Cheapest complete recurring price in our index

Eden Health GLP-1

$99/mo month-to-month, from $34 on a plan · 6.9/10 · Both

Both Hume Care and MEDVi start above the cheapest complete recurring program we track. Across all 36 providers in our index, the lowest price with affirmative medication, consultation, and shipping inclusion is Eden Health GLP-1 at $99/mo, price checked August 28, 2026. It scores 6.9/10 and is not the highest-scored provider in our full rankings, so this is a cost floor rather than a recommendation. Worth knowing before you decide.